1. Home
  2. SVM vs XERS Comparison

SVM vs XERS Comparison

Compare SVM & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVM
  • XERS
  • Stock Information
  • Founded
  • SVM N/A
  • XERS 2005
  • Country
  • SVM Canada
  • XERS United States
  • Employees
  • SVM N/A
  • XERS N/A
  • Industry
  • SVM Precious Metals
  • XERS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVM Basic Materials
  • XERS Health Care
  • Exchange
  • SVM Nasdaq
  • XERS Nasdaq
  • Market Cap
  • SVM 1.4B
  • XERS 1.3B
  • IPO Year
  • SVM N/A
  • XERS 2018
  • Fundamental
  • Price
  • SVM $7.00
  • XERS $8.20
  • Analyst Decision
  • SVM Strong Buy
  • XERS Strong Buy
  • Analyst Count
  • SVM 1
  • XERS 7
  • Target Price
  • SVM $6.75
  • XERS $8.00
  • AVG Volume (30 Days)
  • SVM 7.0M
  • XERS 2.1M
  • Earning Date
  • SVM 11-06-2025
  • XERS 11-07-2025
  • Dividend Yield
  • SVM 0.36%
  • XERS N/A
  • EPS Growth
  • SVM N/A
  • XERS N/A
  • EPS
  • SVM 0.25
  • XERS N/A
  • Revenue
  • SVM $308,064,000.00
  • XERS $246,025,000.00
  • Revenue This Year
  • SVM $6.17
  • XERS $43.89
  • Revenue Next Year
  • SVM $35.69
  • XERS $20.40
  • P/E Ratio
  • SVM $28.11
  • XERS N/A
  • Revenue Growth
  • SVM 35.50
  • XERS 35.62
  • 52 Week Low
  • SVM $2.87
  • XERS $2.73
  • 52 Week High
  • SVM $7.26
  • XERS $8.51
  • Technical
  • Relative Strength Index (RSI)
  • SVM 82.54
  • XERS 59.59
  • Support Level
  • SVM $6.28
  • XERS $7.88
  • Resistance Level
  • SVM $6.76
  • XERS $8.26
  • Average True Range (ATR)
  • SVM 0.35
  • XERS 0.35
  • MACD
  • SVM 0.11
  • XERS -0.01
  • Stochastic Oscillator
  • SVM 88.27
  • XERS 74.90

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Share on Social Networks: